Shaili Desai | Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy

Insurance Accepted

Aetna Blue Cross of California Blue Shield of California Cigna Humana

Northeast Ohio Medical University

Medical School

University Hospital - University of Cincinnati

Residency

University Hospital - University of Cincinnati

Fellowship

MI State Medical License: 2013 - 2018

OH State Medical License: 2012 - 2019

American Board of Internal Medicine: Medical Oncology

American Board of Internal Medicine: Hematology

American Board of Internal Medicine: Internal Medicine

American Board of Internal Medicine - Oncology

Dr. Shaili Desai has contributed to 1 publications.

Thromboembolic events in patients with colorectal cancer receiving the combination of bevacizumab-based chemotherapy and erythropoietin stimulating agents.

Roddy, J. V., Partridge, S. M., Rockey, M. L., Pruemer, J. M., Guo, J. J., Desai, S. J., Safa, M. M.; Am J Clin Oncol. 2010 Feb 01.

Bio & Insurance Information

Insurance Accepted

Aetna Blue Cross of California Blue Shield of California Cigna Humana
Education & Training

Northeast Ohio Medical University
Medical School
University Hospital - University of Cincinnati
Residency
University Hospital - University of Cincinnati
Fellowship
Board Certifications

American Board of Internal Medicine - Oncology
Publications & Memberships

Dr. Shaili Desai has contributed to 1 publications.

Thromboembolic events in patients with colorectal cancer receiving the combination of bevacizumab-based chemotherapy and erythropoietin stimulating agents.

Roddy, J. V., Partridge, S. M., Rockey, M. L., Pruemer, J. M., Guo, J. J., Desai, S. J., Safa, M. M.; Am J Clin Oncol. 2010 Feb 01.
See more >>

Request a call back

Request a call back

Insurance Accepted

Dr. Shaili Desai has contributed to 1 publications.

Insurance Accepted

Dr. Shaili Desai has contributed to 1 publications.